Related Experiment Videos
Homomeric interactions between type II transforming growth factor-beta receptors
1Department of Growth and Development, University of California, San Francisco 94143-0640.
The Journal of Biological Chemistry
|September 9, 1994
Summary
Transforming growth factor-beta (TGF-beta) type II receptors form homomeric complexes independently of TGF-beta. This pre-formed receptor complex binds TGF-beta, suggesting a new activation mechanism for serine/threonine kinase receptors.
Area of Science:
- Molecular and Cellular Biology
- Receptor Signaling Pathways
- Protein-Protein Interactions
Background:
- Transforming growth factor-beta (TGF-beta) signals through cell-surface receptors, primarily type I and type II serine/threonine kinases.
- These receptors are believed to form heteromeric complexes upon TGF-beta binding to mediate cellular responses.
- The self-assembly properties of type II receptors, independent of ligand, were not well understood.
Purpose of the Study:
- To investigate whether type II TGF-beta receptors can form homomeric complexes.
- To determine if homomeric complex formation occurs in the presence or absence of the TGF-beta ligand.
- To elucidate the domains involved in type II receptor homodimerization.
Main Methods:
- Metabolic labeling of cells.
- Co-transfection with differentially epitope-tagged type II receptors.
- Double immunoprecipitation analyses of cell lysates.
Main Results:
- Type II TGF-beta receptors form homomeric complexes even without TGF-beta binding.
- These pre-formed homomeric type II receptor complexes are capable of binding TGF-beta.
- Interaction occurs between extracellular, transmembrane, and cytoplasmic domains, indicating multiple contact sites.
Conclusions:
- Type II TGF-beta receptors can self-assemble into homomeric complexes prior to ligand engagement.
- This pre-association suggests a novel mechanism for receptor complex formation and activation within the serine/threonine kinase receptor family.
- The findings reveal a new layer of regulation in TGF-beta signaling pathways.